Gout- Colchicine DI Flashcards
Colchicine MoA
Inhibits beta-tubulin polymerization into microtubules
Also prevents activation, degredation, and migration of neutrophils
Colchicine flare dosing
1.2mg x1, then 0.6mg 1 hour later
Colchicine prophy dosing
0.6mg PO QD-BID
Colchicine dose adjustments for renal and hepatic impairment
Renal impairment: dose adjust when CrCl <30ml/min
Guidelines don’t state specific recommendations for hepatic dosing, but lower the dose if used
Colchicine ADEs
GI symptoms (diarrhea)
Hematologic abnormalities (cytopenias like thrombocytopenia)
Rhabdomyolysis
Who is at risk for rhabdomyolysis from colchicine?
Elderly patients and renal dysfunction patients
Colchicine CI
Concurrent use of colchicine with P-gp or strong CYP3A4 inhibitors is CI’ed in renal and hepatic impairment
Colchicine DDIs: strong CYP3A4 inhibitors
Clarithromycin, darunavir/ritonavir, itraconazole, ketoconazole
Colchicine DDIs: moderate CYP3A4 inhibitors
Diltiazem, erythromycin, fluconazole, verapamil
Colchicine DDIs: P-gp inhibitors
Cyclosporine, amiodarone, ranolazine
The one big no-no with colchicine therapy
If you use it for prophy, don’t use it for flare treatment!